Home >
Medicine Info >
CB-LIN 0.25 mg Tablet
Loading interface...

CB-LIN 0.25 mg Tablet

Manufactured bySerum Institute Of India Ltd.
ContainsCabergoline
Description
CB-LIN 0.25 mg Tablet is a medicine used in the treatment of hyperprolactinemia (abnormally high level of a hormone called prolactin in the body). It works by decreasing the level of prolactin (a chemical substance responsible for breast development and milk production in women) in the body. The higher dose of this medicine (1mg) is also used as a second-line treatment for Parkinson’s disease (a brain disorder that causes uncontrolled movements). CB-LIN 0.25 mg Tablet shows common side effects such as constipation, stomach pain, nausea, vomiting, and tiredness. These side effects usually subside with time. However, if they persist or become worse, consult your doctor for further assistance. Avoid driving vehicles or operating heavy machines while taking this medication, as it can cause dizziness or drowsiness. CB-LIN 0.25 mg Tablet can be taken with or without food. Follow all the instructions given by your doctor. Take the tablet at the same time daily for the ease of remembering. Do not take more than the recommended dose. Avoid the discontinuation of this medicine without consulting your doctor, as it may worsen your condition. CB-LIN 0.25 mg Tablet is not recommended if you are allergic to it. It is not recommended if you have abnormally high blood pressure, a heart valve condition (improper functioning of your heart valves), or have had fibrosis (scar tissue) affecting your heart, lungs, or abdomen. It should be used with caution if you have a history of liver or heart problems or high blood pressure due to pregnancy. CB-LIN 0.25 mg Tablet is not recommended for use during pregnancy and while breastfeeding. Hence consult your doctor before taking this medicine.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for CB-LIN 0.25 mg Tablet

Caberlin 0.25 mg Tablet
Sun Pharma Laboratories Ltd.
Cabgolin 0.25 mg Tablet
Sun Pharma Laboratories Ltd.
Cabgon 0.25 mg Tablet
Intas Pharmaceuticals Ltd.
Cabliz 0.25 mg Tablet
Macleods Pharmaceuticals Pvt. Ltd.
Colette 0.25 mg Tablet
Cipla Ltd.

Side effects

Major & minor side effects for CB-LIN 0.25 mg Tablet

  • Hypersensitivity
  • Swelling of ankles or feet
  • Breast pain
  • Heartburn
  • Constipation
  • Nausea and vomiting
  • Blurred vision
  • Difficulty in breathing
  • Dizziness
  • Drowsiness

Uses of CB-LIN 0.25 mg Tablet

What is it prescribed for?

  • Hyperprolactinemia
  • Parkinson's condition
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    CB-LIN 0.25 mg Tablet starts to show its effect within three hours.
  • How long do the effects of this medicine last?
    CB-LIN 0.25 mg Tablet remains effective in the body for 14 days.
  • Is it safe to consume alcohol while taking this medicine?
    Avoid consumption of alcohol while taking CB-LIN 0.25 mg Tablet as it may increase the risk of side effects such as dizziness, drowsiness, in difficulty concentrating.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for CB-LIN 0.25 mg Tablet.
  • Can this medicine be taken during pregnancy?
    CB-LIN 0.25 mg Tablet is not recommended for use in pregnancy unless necessary. Consult your doctor before taking this medicine if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    CB-LIN 0.25 mg Tablet is not recommended for use while breastfeeding as it can suppress milk production. Consult your doctor if you are breastfeeding.

Allergy

Avoid taking CB-LIN 0.25 mg Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.

Hypertension

Hypertension refers to high blood pressure. CB-LIN 0.25 mg Tablet is not recommended if you have uncontrolled hypertension as it can worsen your condition.

Heart valve condition

A heart valve condition is when the valve (flaps present in the heart, which allows the blood to flow only in one direction) does not function properly leading to difficulty in blood supply. CB-LIN 0.25 mg Tablet is not recommended if you have such a condition as it may worsen your condition.

Fibrosis

Fibrosis is the abnormal scarring or thickening of tissue in or around the internal organs leading to injury. CB-LIN 0.25 mg Tablet is not recommended if you have fibrosis affecting the heart, lungs, or stomach, as it can contribute to the progression of fibrosis.
Warnings for special population

Pregnancy

CB-LIN 0.25 mg Tablet is not recommended for use in pregnancy unless necessary. Consult your doctor before taking this medicine if you are pregnant.

Breast-feeding

CB-LIN 0.25 mg Tablet is not recommended for use while breastfeeding as it can suppress milk production. Consult your doctor if you are breastfeeding.
General warnings

Use in children

CB-LIN 0.25 mg Tablet is not recommended for use in children below 18 years of age due to the lack of safety and efficacy data.

Lactation suppression

CB-LIN 0.25 mg Tablet is not recommended for suppressing milk production due to the increased risk of serious side effects such as stroke, hypertension, and seizures.

Missed Dose

Do not miss the dose of CB-LIN 0.25 mg Tablet. Take the missed dose as soon as you remember it. If it is time for your next dose, skip the missed dose. Do not double your dose to make up for the missed dose.

Overdose

Do not take more than the recommended dose. Seek emergency medical treatment in case of an overdose of CB-LIN 0.25 mg Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Avoid consumption of alcohol while taking CB-LIN 0.25 mg Tablet as it may increase the risk of side effects such as dizziness, drowsiness, in difficulty concentrating.
Interaction with Medicine

Acebutolol

Bisoprolol

Disease interactions

Psychosis

Psychosis is a mental condition in which a person gets disconnected from reality. CB-LIN 0.25 mg Tablet should be used with caution in such a condition as it can worsen your symptoms such as false beliefs, agitation, and seeing unrealistic things. Your doctor will carefully monitor your condition if you are taking this tablet.

Liver Disease

CB-LIN 0.25 mg Tablet is broken down by the liver. Hence it should be used with caution if you have liver problems as it may cause an accumulation of this medicine in the body and increase the risk of side effects. Your doctor may suggest tests to monitor your liver function during treatment with this medicine.

Hypotension

Hypotension refers to low blood pressure. CB-LIN 0.25 mg Tablet should be used cautiously as it may cause hypotension. Follow all the instructions given by your doctor while taking the tablet.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take CB-LIN 0.25 mg Tablet with or without food. Do not break, chew, or crush the tablet. Take CB-LIN 0.25 mg Tablet as directed by your doctor. Avoid taking more than the recommended dose. Avoid the consumption of alcohol while taking this medicine due to the increased risk of side effects. Your doctor may suggest periodic blood tests to monitor your prolactin levels.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
CB-LIN 0.25 mg Tablet works by decreasing the level of prolactin (a hormone responsible for breast development and milk production in women) in the body. It also promotes the release of a chemical substance called dopamine in the body.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Dopamine agonists, Prolactin inhibitors

Schedule

Schedule H

Drugs, H., 2022. Cabergoline: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: [Accessed 1 July 2022].

https://medlineplus.gov/druginfo/meds/a612020.html

Hpra.ie. 2022. [online] Available at: [Accessed 14 July 2022].

https://www.hpra.ie/img/uploaded/swedocuments/2202886.PA0822_114_001.bea0751d-d70e-4146-bd17-6ef668151508.000001Cabaser%20PIL.180226.pdf

Accessdata.fda.gov. 2022. [online] Available at: [Accessed 14 July 2022].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020664s011lbl.pdf
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 14 Jul 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.